Inactive Instrument
Lipidor AB Share Price
Stocks
L7R
SE0012558617
Pharmaceuticals
OTC Markets Traded| Manager | Title | Age | Since |
|---|---|---|---|
Ola Holmlund
CEO | Chief Executive Officer | 57 | 31/12/2017 |
Jan Holmbäck
CTO | Chief Tech/Sci/R&D Officer | 69 | 31/12/2009 |
Charlotta Ekman
DFI | Director of Finance/CFO | 45 | 30/09/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Ola Flink
CHM | Chairman | 82 | 31/12/2016 |
| Chairman | 46 | 31/12/2019 | |
Gunilla Lundmark
BRD | Director/Board Member | 63 | 31/05/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -98.73% | - | - | 92.63K | |
| +0.28% | +3.46% | +41.89% | +93.71% | 1,054B | |
| +0.88% | +4.27% | +38.28% | +68.70% | 636B | |
| +1.68% | +5.78% | +21.96% | +89.56% | 497B | |
| -0.10% | +4.24% | +69.15% | +40.41% | 359B | |
| +0.61% | +3.18% | +24.05% | +42.46% | 345B | |
| +0.72% | +2.99% | +14.29% | +34.71% | 273B | |
| +0.23% | +2.23% | -5.91% | +8.15% | 246B | |
| +0.65% | +3.62% | +43.93% | +46.50% | 226B | |
| -0.49% | +4.01% | +28.38% | +95.97% | 187B | |
| Average | +0.39% | +3.14% | +30.67% | +57.80% | 424.69B | |
| Weighted average by Cap. | +0.42% | +3.19% | +34.05% | +66.97% |
Employees
4
Sector
Pharmaceuticals
